Hasanbeigi Et Al
Hasanbeigi Et Al
Hasanbeigi Et Al
cases in implantation. a questionnaire was completed for each patient. The samples were transferred to the
microbiology laboratory of Ilam Medical University and were implanted in sabouraud dextrose agar
environments including chloramphenicol and last incubated for 48 hours at the temperature of 37. then LAM
was produced from the clones grown on the environment and in case of existence of yeast cells, they were
identified using standard methods like tube mass, sensitivity to cycloheximide, temperature test and sugar
attraction test and were classified as Candida Albicans and non-Candida Albicans (16). Stock was produced
from affirmed fungus samples and was kept at -20 temperature. Candida albicans ATCC 2091 was used as the
standard type (17). In order to investigate sensitivity pattern and drug resistance of the yeasts, disk diffiusion
method was used according to CLSI M44-A standard, in a way that a suspension of yeast clones in sterile
distilled water with the standard MCfarland opacity of 0.5 was produced and using swap sterile, they were
implanted in a Moller Hinton AGAR environment which included %2 Glucose and 0.5 mg/ml methylene blue
then Nystatin, fluconazole, Ktokonazol and Itraconazole, disks were situated on the implanting environment in
certain distances. After 20 to 24 hours of incubation at 37c temperature, the diameter of coronas of lach of
growth near the disks was measured and the amount of sensitivity and resistance of each of samples was
reported according to standard amounts. The data were analyzed using SPSS version 16 and statistical test x2
and T- test.
Results:
Among 200 samples of oral thrush and diaper dermatitis. 101 samples were positive considering the type of
candida. Also among the 101 samples, the most prevalent type was that of Candida albicans (68.5). 43.6 of the
children were born by Caesarian Section and %15.4 of the patients more than one time afflicted to candida
infection. %24.8 of the children used powdered milk, 70.5 used mother milk and 4.7 used both, which had no
significant relation to candida infection (P>%5) (Table.1). Also %100 of Candida albicans Samples separated
from Oral thrush were sensitive to Nystatin.The amount of sensitivity of all candida to Nystatin, Fluconazole,
Ketoconazole and Itraconazole were %6, %37, %37.5 and %47 respectively.
Discussion:
Regarding the emergence of types of candida resistant to anti fungus drugs and the side effects of these drugs,
(18) determining the drug resistance pattern of types of candida to anti fungus drugs can be of special
importance. In this study, the most prevalent type was that of candida albicans including %68.5 which is in
agreement with other studies (16, 19, and 20). Among the candida separated from oral thrush and diaper
dermatitis, %62.4 of the children were between 1 to 3 years of age. So this age is the prevalent age for children
to be afflicted with diaper dermatitis and this is in agreement with previous findings (21). In this study, nutrition
had no significant relationship with affliction to candida infection and this result is in agreement with Lee s
study in 2012 (22). There was no significant relationship between taking anti bistics and Korton with affliction
to candida infection. Of course this can affect the resistance or sensitivity of tested samples. However, in Huke
et al. study in 2003 which investigated the candidiasis factors risk, it was demons treated that recent
consumption of antibiotics and corticosteroids has a significant relationship with candidiasis infection (23). In
Sharma et al. study in 2013 which was conducted on 150 types of Candida isolated from oral thrush of HIV
patients, the resistance of Candida albicans types to fluconazole was reported as %34.07 which was similar to
our study (%33.3). However, in a study by Buddy et al. in 2011, which was conducted on 595 Candida types,
the resistance of Candida albicans to fluconazole was reported as %15.5 (25). In Abasi et al. study in 2011, the
resistance of Candida albicans to fluconazole was reported as %59/6 (26). However in Ozklik et al. Study, in
2006, %100 of candida were sensitive to fluconazole (27). This difference is probably due to excessive use of
anti- fungus drugs or the genetics if types of candida in different parts of the world. in this study the percentage
of resistance to Nystatin was %6, which is in agreement with Mulu and salami study conducted in 2010 and
2011 (29, 28). According to results, Nystatin can be suggested as the main drug to cure this candida. in Mulu et
al. study in 2013 which was conducted on 177 types of candida separated from oral wounds of those afflicted
with HIV, the amount of resistance to ketoconazole and Itraconazole fungus was reported %4.7 and %7.7
respectively, which in the current research, the amount of resistance to fungus was more than the above
mentioned study and %37.5 and %47 respectively (30). Also in Johnson et al. study in 2009, all Candida isolates
were resistant to Itraconazole (31). However, in Falahat et al. study in 1388, the resistance of Candida types to
ketoconazole was reported %85/7 (16). these differences are probably due to difference in the studied
population or the purity of the drugs.
Conclusion:
Regarding the results of this study which showed little resistance to Nystatin, and because Nystatin is used
locally, its side effects and drug resistance are less than systematic anti fungus drugs. The suggested drug is to
be used in Nystatin candidiasis.
References:
[1] panahi Y, sharif MR, sharif A, et al. A Randomized Comparative trial on the therapeutic efficacy of topical Aloevera and calendula
officinalis on Diaper Dermatitis in children. Scientific World Journal 2012; 2012: 81-88.
[2] Singalavanija S, Frieden IJ. Diaper Dermatitis pediatr Rev 1995; 16: 142-48.
[3] Ward DB, Fleischer AB, Feldman SR, Rowchuk DP. Characterization of diaper dermatitis in the United States, Arch pediatr Adolesc
Med 2000; 154: 943-42.
[4] Wolf R, Wolf D, Tuzun B. Diaper dermatitis. Clin Dermatol 2000; 18: 657-61.
[5] Shay K, Truhlar MK, Kenner RP. Oropharyngeal candidiasis in older patient. JAM Geriatr Soc 1997; 45: 86368.
[6] Katiraee F, Aidi S, Bahonar AR, Zarinfar H, Khosravi AR. The minimum inhibitory concentration(MIC) Some essential oils native
plant in Iran on growth of Candida albicans of resistant and sensitive to Azole drugs. J of Medicinal Plants 2008; 3(27): 38-44.
[7] Sangeorzan JA, Bradley SF, He X, et al. Epidemiology of oral candidiasis in HIV infected patients: colonization, infection, treatment
and emergence of fluconazole resistance, Am Jmed 1994; 97: 339-403.
[8] Arnsmeier Sl, Paller AS. Getting to the bottom of diaper dermatitis .Contemporary pediatr 1997; 14: 115-21.
[9] Champion RH, Burton JL, Burns DA. Rook textbook of dermatology. 6th ed. London: lackwell, 1998: 468-472.
[10] Spraker MK, Gisoldi EM, Sieg fried EC, et al. Topical miconazole nitrate ointment in the treatment of diaper dermatitis complicated
by candidiasis. Cutis 2006; 77: 113-18.
[11] Vazquez JA, skiest DJ, Nietol B, et al. A multicenter randomized trial evaluating Posaconazole versus fluconazole for the treatment of
oropharyngeal candidiasis in subjects with HIV /AIDS . Clin Infect Dis 2006; 42: 1179-84.
[12] Mohamad-asghari H, Gharib A, Faezi-zadeh Z. Evaluation Efficiency and Toxicity of nano-capsules containing amphotericin B in
vitro. J Modares Med Sci-Biological pathology 2010; 13(3): 1-10.
[13] Morgan J. Global trends in candidemia: review of reports from 1995-2005. Curr Infect Dis Rep 2005; 7(6): 429-39.
[14] Jabra-Rizk MA, Falkler WA, Meiller TF. Fungal biofilms and drug resistance. Emerg Infect Dis 2004; 10(1): 14-9.
[15] Katiraee F, Khosravi AR, Khalaj V, Hajiabdolbaghi M, Khaksar AA, Rasoulinejad M. In vitro antifungal susceptibility of oral candida
species from Iranian HIV infected patients.J of Tehran Uni Med Sci 2012; 70(2): 96-103.
[16] Falahati M, Sharifinia S, Foroumadi AR, Bolouri F, Akhlagh L, Yazdan Parast A, et al,. Drug Resistance Pattern in Candida Species
Isolated from Vaginitis. J of Iran Uni Med Sci 2009; 16(65): 40-5.
[17] NCCLS. Method for Antifungal Disk Diffusion Susceptibility Testing of Yeasts; Approved Guideline.NCCLS document M44-A
[ISBN 1-56238-532-1]. NCCLS, 940 West Valley Road, Suite 1400, Wayne,Pennsylvania 19087-1898 USA, 2004.
[18] Elias J. Anaissie, Michael R. McGinnis, Michael Pfaller. Clinical Mycology 2003; 195-227.
[19] Consolaro MEL, Albetoni TA, Yoshida CS, Mazucheli J, Peralta RM, Svidzinski TIE. Correlatin of candida species and symptoms
among patients with vulvovaginal candidiasis in marina parana Brazil. Rev Iberoam Micol 2004; 21: 202-5.
[20] El-Din SS, Reynolds MT, Ashbe HR, Barton RC, Evans EGV. An investigation into the pathogenesis of vulvo-vaginal candidasis.Sex
Transm Inf 2001; 77: 179-83.
[21] Nield LS, Kamat D. Prevention, diagnosis, and management of diaper dermatitis. Clin Pediatr 2007; 46: 480-6.
[22] Li C, Zhu Z, Dai Y. Diaper Dermatitis: A Survey of Risk Factors for Children Aged 124 Months in China. Journal of International
Medical Research 2012; 40(5):1752-60.
[23] Hyeuk-Choi J, Lee C, Lim YJ, Kang HW, Lim CY, Choi J. Prevalence and Risk Factors of Esophageal Candidiasis in Healthy
Individuals: A Single Center Experience in Korea. Yonsei Med J 2013; 54(1):1605.
[24] Sharma P, Rajaram More S, Raut S, Rathod SV. In Vitro Antifungal Susceptibility Pattern of Oropharyngeal and Oesophageal
Candida Species in HIV Infected Patients 2013: 2249-9571.
[25] Jang MJ, Shin JH, Lee WG, Kim MN, Lee K, Lee HS, et al,. In vitro fluconazole and voriconazole susceptibilities of Candida
bloodstream isolates in Korea: use of the CLSI and EUCAST epidemiological cutoff values. Ann Lab Med 2013; 33(3):167-73.
[26] Abaci O, Haliki-Uztan A. Investigation of the susceptibility of Candida species isolated from denture wearers to different antifungal
antibiotics. African Journal of Microbiology Research 2011; 5(12):1398-403.
[27] Ozlcelic B, Kayank F, Cesur S, Sipahi B, Sultan N. Invitro activities of voriconazole as triazolederivative and caspofungin as an
echinocandin were compared with those of some antifungal agents against candida species isolated from clinical specimens. Infect Dis
2007; 60: 302-4.
[28] Sellami A, Sellami H, Nji S, Makni F, Abbes S, Cheikhrouhou F,et al. Antifungal susceptibility of bloodstream Candida isolates in
Sfax hospital: Tunisia. Mycopathologia. 2011; 171(6):417-22.
[29] Moallaie H, Verissimo C, Brando J, Rosado L. THE SENSITIVITY AND RESISTANCE OF YEASTS ISOLATED FROM WOMEN
WITH VULVOVAGINAL CANDIDIASIS TO COMMON ANTIFUNGAL DRUGS USING DISC DIFFUSION. Journal of Sabzevar
University of Medical Sciences 2010 ; 16 (4) :213-219
[30] Mulu A, Kassu A, Anagaw B, Moges B, Gelaw A, Alemayehu M.,et al. Frequent detection of 'azole' resistant Candida species among
late presenting AIDS patients in northwest Ethiopia. BMC Infect Dis. 2013; 12; 13:82.
[31] Johnson EM. Rare and emerging Candida species. Current Fungal Infection Reports 2009; 3:152-9.
Oral Diaper
Both P Value
Candidiasis dermatitis
Age
>1 3.3 11.5
(Frequency) (2) (10)
68.3 58.6 50
1-3 0.07
(41) (51) (1)
25 18.4
4-7
(15) (16)
3.3 11.5 50
<7
(2) (10) (1)
powdered
Nutrition
18.3 29.9
milk
(11) (26)
(Frequency)
mother 0.42
75 66.7 100
milk
(45) (58) (2)
(Frequency)
Both 6.7 3.4
(Frequency) (4) (3)
Antifungal use